Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Kindred Biosciences Company Profile (NYSE:KIN)

Consensus Ratings for Kindred Biosciences (NYSE:KIN) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.88 (45.22% upside)

Analysts' Ratings History for Kindred Biosciences (NYSE:KIN)
Show:
DateFirmActionRatingPrice TargetActions
5/19/2015ZacksUpgradeHold -> Buy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015ZacksDowngradeOutperform -> Neutral$8.10View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Craig HallumDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Leerink SwannDowngradeOutperform -> Market Perform$11.25 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014BMO Capital MarketsReiterated RatingOutperform$19.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014ZacksUpgradeNeutral -> Outperform$11.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014BMO Capital MarketsLower Price Target$30.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014Leerink SwannLower Price Target$29.00 -> $11.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014Roth CapitalLower Price Target$11.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2014Craig HallumInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2014Leerink SwannBoost Price Target$29.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2014Roth CapitalLower Price Target$18.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2014Leerink SwannInitiated CoverageOutperform$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2014Roth CapitalLower Price Target$25.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2014Roth CapitalDowngradeBuy -> Neutral$20.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014BMO Capital MarketsUpgradeMarket Perform -> Outperform$15.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Roth CapitalInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2014BMO Capital MarketsDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014GuggenheimInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2014BMO Capital MarketsInitiated CoverageOutperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2013 forward)